Bank of New York Mellon Corp
BankPosition in ANIK — Anika Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in ANIK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$567,247
-$9,374 QoQ
Shares Held
38,773
-2.5% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. ANIK ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in ANIK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $567,247 | 38,773 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $576,621 | 39,767 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $389,251 | 40,505 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $470,844 | 50,090 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $497,586 | 47,031 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $726,758 | 48,354 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $831,705 | 50,529 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,032,901 | 41,818 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,557,287 | 61,480 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,296,441 | 51,041 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,257,152 | 55,479 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,138,253 | 61,098 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,613,348 | 139,082 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $4,159,228 | 144,820 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $4,345,901 | 146,821 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,581,447 | 150,481 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,079,042 | 137,950 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,342,215 | 133,103 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,738,838 | 132,259 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,932,266 | 139,386 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $6,179,732 | 142,752 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $6,437,028 | 157,809 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $7,205,254 | 159,197 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $5,860,583 | 165,600 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,715,857 | 204,502 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $6,045,917 | 209,129 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||